What is Anterior?
Clinician-led AI platform that helps health plans automate administrative workflows.
- Category
- Healthcare AI
- Headquarters
- New York, NY
- Founded
- 2023
- Employees
- 50-150 estimated
- Total funding
- $64M disclosed
- Valuation
- Not disclosed
What is Anterior?
Clinician-led AI platform that helps health plans automate administrative workflows.
Anterior is clinician-led AI platform that helps health plans automate administrative workflows. Public scale signal: $64M raised and public positioning around reducing a $950B U.S. healthcare administrative burden. The company operates in Healthcare AI, where product credibility, data quality, compliance, customer trust, and speed of execution shape the market.
This profile uses public sources as of June 2026 and avoids inventing private revenue, undisclosed pricing, office lists, personal emails, or internal vendor stacks. Sequoia provenance is included where Sequoia lists the company, published a company profile, or is named in a financing announcement.
For sellers, the practical read is that Anterior buys around its operating model: enterprise healthcare AI contracts based on workflows, volume, integrations, clinical review, support, and ROI. Outreach should connect directly to executive priorities, measurable ROI, security review, and the teams that own the workflow.
What does Anterior offer?
Anterior offers Prior authorization, Payment integrity, Risk adjustment, Clinical AI copilots, Clinician review loop and related workflows.
- Prior authorization· Payer workflow
- Payment integrity· Payer workflow
- Risk adjustment· Payer workflow
- Clinical AI copilots· AI platform
- Clinician review loop· Quality
- Workflow ROI reporting· Operations
How does Anterior make money?
Anterior monetizes through enterprise healthcare AI contracts based on workflows, volume, integrations, clinical review, support, and ROI.
Anterior's public pricing view is: no public list pricing; enterprise health-plan contracts. Where list prices are not published, this profile treats pricing as custom rather than inferring hidden rates or contract values.
The business model is enterprise healthcare AI contracts based on workflows, volume, integrations, clinical review, support, and ROI. Growth is driven by adoption, retention, usage expansion, product attach, geographic reach, and the ability to prove measurable customer value.
Seller signal: budget owners vary by purchase category, but finance, security, legal, procurement, product, engineering, operations, and the business sponsor usually need to align before larger contracts close.
Who leads Anterior?
Anterior is led by Abdel Mahmoud, MD with Clinical and AI platform leadership and a scaling operating team.
- Abdel Mahmoud, MDFounder and CEOFounder; partnered with Sequoia in 2023Clinician-founder leading payer AI strategy and fundraising.
- Clinical operations leadershipClinical and payer workflow leadersScaling teamStakeholders for accuracy, safety, and health-plan implementation.
- Engineering and product leadershipAI platform leadersScaling teamOwn integration, model workflow, data, and deployment architecture.
How do you contact Anterior's leadership?
Anterior does not publish verified personal executive emails in the reviewed sources. Use official contact, demo, support, investor, or careers routes instead of guessed personal addresses.
Personal executive email format not verified; use official company routesHow much funding has Anterior raised?
Anterior's funding/status view is $64M disclosed; latest valuation/status is Not disclosed.
Anterior's disclosed capital history includes: 2023 Founded / Sequoia partnership (Anterior begins building clinician-led AI for health-plan administrative workflows.) 2024 Series A (Coverage reports a $20M Series A led by NEA with Sequoia participation.) 2024 Florence and payer workflows (Anterior discusses AI support for prior authorization and administrative clinical tasks.) Feb 2026 $40M round (Anterior raises $40M, bringing total funding to $64M.) 2026 Health-plan AI expansion (Company positions around moving payers from proof of concept to proof of result.)
The latest funding/status view is Feb 2026 $40M round; latest valuation/status is Not disclosed. If valuation is not disclosed, this profile says so rather than using secondary-market guesses. For public, acquired, or pre-IPO companies, status and operating scale can be more useful than old private round labels.
Seller signal: funding indicates potential operating capacity, but not automatic budget. Tie outreach to the initiatives named in the round, the company's current scale, and procurement maturity.
How did Anterior get here?
Anterior reached its current stage through founding, financing, product expansion, and market traction milestones.
- 2023Founded / Sequoia partnershipAnterior begins building clinician-led AI for health-plan administrative workflows.
- 2024Series ACoverage reports a $20M Series A led by NEA with Sequoia participation.
- 2024Florence and payer workflowsAnterior discusses AI support for prior authorization and administrative clinical tasks.
- Feb 2026$40M roundAnterior raises $40M, bringing total funding to $64M.
- 2026Health-plan AI expansionCompany positions around moving payers from proof of concept to proof of result.
Who are Anterior's competitors?
Anterior competes with category-specific vendors and adjacent platforms that solve parts of the same workflow.
- Cohere HealthPrior authorization and care-pathway automation platform for health plans.
- XSOLISAI-enabled utilization management and payer-provider collaboration.
- MCG HealthClinical guidelines and authorization workflow tools used by payers and providers.
- NymClinical language understanding and autonomous medical coding automation.
- ApixioAI and data products for risk adjustment and payment integrity.
Anterior — frequently asked questions
